PCI Registered Reports

SINCLAIR-HOUSE Nicholas

School of Law, Politics and Sociology, University of Sussex, Brighton, United Kingdom
ocial science

Recommendations: 0

Reviews: 2

10 Feb 2023

STAGE 2
(Go to stage 1)

The labels and models used to describe problematic substance use impact discrete elements of stigma: A Registered Report

Charlotte R. Pennington, Rebecca L. Monk, Derek Heim, Abi K. Rose, Thomas Gough, Ross Clarke, Graham Knibb, Roshni Patel, Priya Rai, Halimah Ravat, Ramsha Ali, Georgiana Anastasiou, Fatemeh Asgari, Eve Bate, Tara Bourke, Jayme Boyles, Alix Campbell, Nic Fowler, Sian Hester, Charlotte Neil, Beth McIntyre, Ellie Ogilvy, Amie Renouf, Joni Stafford, Katie Toothill, Hin Kok Wong, Andrew Jones https://osf.io/z9bnf

Different ways of describing problematic substance use and its treatment influence public stigma

Recommended by Zoltan Dienes based on reviews by Nicholas Sinclair-House

People experiencing problematic substance use are often stigmatised by the general public. This public stigma may impair such people obtaining help and the quality of help that they receive. For this reason, previous research has investigated the factors that may exacerbate or lessen stigma by focusing on the terminology used to describe problematic substance use. However, the evidence is not clear cut, with some studies suggesting that labelling the condition as a "chronically relapsing brain disease" vs a "problem" reduces certain elements of stigma and other studies finding absence of evidence. A closer look at these studies points to methodological differences that may explain their results, such as whether problematic substance use is compared with another health condition, whether the individual is described as seeking treatment or not, and whether general or discrete elements of stigma are measured.

In this Stage 2 Registered Report, Pennington et al. (2023) isolated these methodological differences to investigate if any of them influenced two different measures of stigma used in previous work. They found that greater social distance, danger and public stigma but lower blame were ascribed to drug use relative to a health concern, supporting previous research to suggest that problematic substance use is a highly stigmatised health condition. Furthermore, greater (genetic) blame was reported when drug use was labelled as a ‘chronically relapsing brain disease’ relative to a ‘problem’. The results for attributional judgement were either inconclusive or statistically equivalent. In summary, these findings suggest that the labels and models used to describe problematic substance use may impact upon public stigma in distinct ways. The authors suggest that future research should justify which measures are being used in line with theory. They also put forward the notion that addiction is a functional attribution, which may explain the mixed literature on the brain disease model of addiction to date.

The Stage 2 manuscript was evaluated over one round of specialist review and several rounds of discussion with the recommender. Based on comprehensive responses, the recommender judged that the manuscript met the Stage 2 criteria and awarded a positive recommendation.

URL to the preregistered Stage 1 protocol: https://osf.io/4vscg

Level of bias control achieved: Level 6. No part of the data or evidence that was used to answer the research question was generated until after IPA.

List of eligible PCI RR-friendly journals:

References

Pennington, C. R., Monk, R. L., Heim, D., Rose, A. K., Gough, T., Clarke, R., Knibb, G., Patel, R., Rai, P., Ravat, H., Ali, R., Anastasiou, G., Asgari, F., Bate, E., Bourke, T., Boyles, J., Campbell, A., Fowler, N., Hester, S., Neil, C., McIntrye, B., Ogilvy, E., Renouf, A., Stafford, J., Toothill, K., Wong, H. K., & Jones, A. (2023). The labels and models used to describe problematic substance use impact discrete elements of stigma: A Registered Report. Stage 2 acceptance of Version 4 by Peer Community in Registered Reports. https://osf.io/z9bnf

25 Jan 2022

STAGE 1

To help or hinder: Do the labels and models used to describe problematic substance use influence public stigma?

Charlotte R. Pennington, Rebecca L. Monk, Derek Heim, Abi K. Rose, Thomas Gough, Ross Clarke, Graeme Knibb, and Andrew Jones. https://osf.io/7e2qm/

Understanding the role of health condition, aetiological labels, and attributional judgements in public stigma toward problematic substance use

Recommended by Zoltan Dienes based on reviews by Nicholas Sinclair-House and Roger Giner-Sorolla

People suffering from substance misuse problems are often stigmatised. Such public stigma may impair such people obtaining help and the quality of help that they receive. For this reason, previous research has investigated the factors that may reduce stigma. Evidence has been found, but not consistently, for the claim that labelling the condition as "chronically relapsing brain disease" vs a "problem" reduces stigma; as does "a health concern" vs " drug use". Another potentially relevant difference that may explain different previous results is describing how effective treatment can be.

In this Stage 1 Registered Report, Pennington et al. (2022) describe how they will investigate if any of these factors affect two different measures of stigma used in previous work, with a study well powered for testing whether the 99% CI lies outside or inside an equivalence region. While the CI being outside the region will straightforwardly justify concluding an effect of interest, a CI within the region will need to be interpreted with due regard to the fact that some effects within the region may be interesting.

The Stage 1 manuscript was evaluated over two rounds of review (including one round of in-depth specialist review). Based on comprehensive responses to the reviewers' comments, the recommender judged that the manuscript met the Stage 1 criteria and therefore awarded in-principle acceptance (IPA).

URL to the preregistered Stage 1 protocol: https://osf.io/4vscg

Level of bias control achieved: Level 6. No part of the data or evidence that will be used to answer the research question yet exists and no part will be generated until after IPA.

List of eligible PCI RR-friendly journals:

References

Pennington, C. R., Monk, R. L., Heim, D., Rose, A. K., Gough, T., Clarke, R., Knibb, G., & Jones, A. (2022). To help or hinder: Do the labels and models used to describe problematic substance use influence public stigma? Stage 1 preregistration, in principle acceptance of version 2 by Peer Community in Registered Reports. https://osf.io/4vscg

SINCLAIR-HOUSE Nicholas

School of Law, Politics and Sociology, University of Sussex, Brighton, United Kingdom
ocial science